FEATURED COMPANIES
- Abbott Laboratories
- B. Braun Melsungen AG
- Dexcom Inc
- Insulet Corporation
- Medtronic
- Owen Mumford Ltd
- MORE
Australia ranked seventh in the world for the prevalence of type 1 diabetes in children and 6th highest for incidence. There is also rising prevalence of particularly type 2 diabetes and rising cases of children and adolescents who are now impated by type 2 diabetes in Australia. Type 1 diabetes typically happens in an early age, its a most common form of childhood diabetes although it can occur at any age. Over 1 million Australians have been diagnosed with diabetes. Australia is dragging behind many western countries in providing affordable access to its people with diabetes to new, proven technologies such as CGM and Insulin pen that can significantly improve the management of diabetes. Australia Diabetes Market is expected to reach USD 2.44 Billion by the year 2025.
The market of Self Monitoring Blood Glucose Device, Continuous Glucose Monitoring (CGM) Device, Insulin Pump, and Insulin Pen are growing due to the rising awareness for diabetes in Australia. Diabetes care in Australia has reached a high level of quality, but there is still an opportunity for further improvement. Diabetes is associated with an uncountable of complications that affect the eyes, feet, kidneys, and cardiovascular health. Besides, diabetes is ranked in the top 10 leading causes of deaths in Australia. Diabetes is a massive challenge to the nation’s health and economy.
Australian Government has essential roles in maintaining access to affordable, high-quality devices and services to support people with diabetes in self-management and treatment. The Australian Government providing support to people with diabetes through the National Diabetes Services Scheme, the Pharmaceutical Benefits Scheme, the Insulin Pump Program, and Medicare. In 2019, Biocon and Mylan N V launched insulin glargine biosimilar Semglee, first insulin PBS in Australia. In 2019, TAL, a leading Australian life insurance specialist, has launched a specialized product to protect people with diabetes mellitus in Australia.
This report titled “Australia Diabetes Market & Forecast, By Self Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement), Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Insulin Pump Analysis- (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies), Insulin Pen Analysis - (User, Types - Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Companies (Eli Lilly and Company, B. Braun Melsungen AG, Ypsomed AG, Artsana S.p.A, BD, Novo Nordisk A/S, Medtronic, Insulet Corporation, Owen Mumford Ltd, LifeScan Inc., Dexcom Inc, Abbott Laboratories and Roche)” provides a complete analysis of Australia Insulin Delivery Devices Market.
Segments Market based on Devices
Continuous Glucose Monitoring (CGM)
Self Monitoring Blood Glucose (SMBG)
Insulin Pen
Insulin Pump
Australia Diabetes Sub-Segment Analysis
1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Artsana S.p.A
4. BD
5. Novo Nordisk A/S
6. Owen Mumford Ltd
7. Ypsomed AG
8. Medtronic
9. Insulet Corporation
10. LifeScan Inc.
11. Abbott Laboratories
12. Roche
13. Dexcom Inc
Key Benefits of the Report
This report provides current market estimates and forecasts for Australia Diabetic Market.
Detailed analysis of the key market segments such as source, geography and applications; provides a comprehensive understanding of the market.
Australia Diabetic Market - Growth Drivers and Challenges.
Key sustainability strategies adopted by market players.
The market of Self Monitoring Blood Glucose Device, Continuous Glucose Monitoring (CGM) Device, Insulin Pump, and Insulin Pen are growing due to the rising awareness for diabetes in Australia. Diabetes care in Australia has reached a high level of quality, but there is still an opportunity for further improvement. Diabetes is associated with an uncountable of complications that affect the eyes, feet, kidneys, and cardiovascular health. Besides, diabetes is ranked in the top 10 leading causes of deaths in Australia. Diabetes is a massive challenge to the nation’s health and economy.
Australian Government has essential roles in maintaining access to affordable, high-quality devices and services to support people with diabetes in self-management and treatment. The Australian Government providing support to people with diabetes through the National Diabetes Services Scheme, the Pharmaceutical Benefits Scheme, the Insulin Pump Program, and Medicare. In 2019, Biocon and Mylan N V launched insulin glargine biosimilar Semglee, first insulin PBS in Australia. In 2019, TAL, a leading Australian life insurance specialist, has launched a specialized product to protect people with diabetes mellitus in Australia.
This report titled “Australia Diabetes Market & Forecast, By Self Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement), Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Insulin Pump Analysis- (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies), Insulin Pen Analysis - (User, Types - Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Companies (Eli Lilly and Company, B. Braun Melsungen AG, Ypsomed AG, Artsana S.p.A, BD, Novo Nordisk A/S, Medtronic, Insulet Corporation, Owen Mumford Ltd, LifeScan Inc., Dexcom Inc, Abbott Laboratories and Roche)” provides a complete analysis of Australia Insulin Delivery Devices Market.
Segments Market based on Devices
Continuous Glucose Monitoring (CGM)
Self Monitoring Blood Glucose (SMBG)
Insulin Pen
Insulin Pump
Australia Diabetes Sub-Segment Analysis
- Continuous Glucose Monitoring (CGM)
- Glucose Sensor Market & Forecast
- CGM Transmitter Market & Forecast
- CGM User
- CGM Reimbursement
- SMBG
- Test Strips Market and Forecast
- Lancet Market and Forecast
- Meter Market and Forecast
- Blood Glucose (SMBG) Users
- Blood Glucose Devices Reimbursement
- Insulin Pen Market
- Disposable Insulin Pen
- Reusable Insulin Pen
- Smart Insulin Pen
- Insulin Pen Needle Market
- Insulin Pen Users
- Reimbursement Policies
- Insulin Pump Market
- Insulin Pump Market
- Insulin Pump Users
- Insulin Pump Products
- Reimbursement Policies
- Company Overview
- Recent Developments
- Financial Insight
1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Artsana S.p.A
4. BD
5. Novo Nordisk A/S
6. Owen Mumford Ltd
7. Ypsomed AG
8. Medtronic
9. Insulet Corporation
10. LifeScan Inc.
11. Abbott Laboratories
12. Roche
13. Dexcom Inc
Key Benefits of the Report
This report provides current market estimates and forecasts for Australia Diabetic Market.
Detailed analysis of the key market segments such as source, geography and applications; provides a comprehensive understanding of the market.
Australia Diabetic Market - Growth Drivers and Challenges.
Key sustainability strategies adopted by market players.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- B. Braun Melsungen AG
- Dexcom Inc
- Insulet Corporation
- Medtronic
- Owen Mumford Ltd
- MORE
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Driver
4.2 Challenges
5. Australia Diabetes Market
6. Australia Diabetes Population
6.1 Type 1 & Type 2 Diabetes Population and Forecast
7. Market Share Analysis - Australia Diabetic
7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) - Australia Market & Users
8.1 Australia - CGM Market by Components
8.1.1 Glucose Sensor Market & Forecast
8.1.2 CGM Transmitter Market & Forecast
8.2 Australia - CGM User (2011 - 2025)
8.3 CGM Reimbursement in Australia
9. Blood Glucose Device (SMBG) - Australia Market & Users
9.1 Market
9.1.1 Type 1 & Type 2 (Diabetes)
9.2 Test Strips Market and Forecast
9.2.1 Type 1 & Type 2 (Diabetes)
9.3 Lancet Market and Forecast
9.3.1 Type 1 & Type 2 (Diabetes)
9.4 Meter Market and Forecast
9.4.1 Type 1 & Type 2 (Diabetes)
9.5 Blood Glucose Device (SMBG) Users
9.5.1 Type 1 & Type 2 (Diabetes)
9.6 Reimbursement of Blood Glucose Devices in Australia
10. Insulin Pen Market & User Analysis
10.1 Insulin Pen User
10.1.1 Disposable Insulin Pen Users
10.1.2 Reusable Insulin Pen Users
10.1.3 Smart Insulin Pen Users
10.2 Insulin Pen Market
10.2.1 Disposable Insulin Pen Market
10.2.2 Reusable Insulin Pen Market
10.2.3 Smart Insulin Pen Market
10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies
11. Insulin Pump Market & Users & Forecast
11.1 Insulin Pump Users & Forecast
11.1.1 Type 1 & Type 2 (Insulin Pump User & Forecast)
11.2 Insulin Pump Market & Forecast
11.2.1 Type 1 & Type 2 (Insulin Pump Market & Forecast)
11.3 Differentiation Points of Insulin Pump Products in Australia
11.3.1 Animas Vibe
11.3.2 Medtronic 530G with Enlite
11.3.3 Insulet OmniPod
11.3.4 Tandem t: slim
11.3.5 Roche Accu-Chek Combo
11.4 Training Model for Patients & HCP - of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
11.4.1 Medtronic
11.5 Insulet Corporation
11.5.1 Training Structure for New Patients - Insulet Corporation
11.6 Animas Corporation
11.6.1 Training Modules for New Patients
11.6.2 Training Modules for HCP (Health Care Professional)
11.7 Tandem Diabetes Care
11.8 Reimbursement Policies on Insulin Pump
12. Insulin Pen - Company Analysis
12.1 B. Braun Melsungen AG
12.1.1 Overview
12.1.2 Initiatives & Recent Developments
12.1.3 Revenue
12.2 Eli Lilly
12.2.1 Overview
12.2.2 Initiatives & Recent Developments
12.2.3 Revenue
12.3 Artsana S.p.A.,
12.3.1 Overview
12.3.2 Initiatives & Recent Developments
12.3.3 Revenue
12.4 BD
12.4.1 Overview
12.4.2 Initiatives & Recent Developments
12.4.3 Revenue
12.5 Novo Nordisk A/S
12.5.1 Overview
12.5.2 Initiatives & Recent Developments
12.5.3 Revenue
12.6 Owen Mumford Ltd.
12.6.1 Overview
12.6.2 Initiatives & Recent Developments
12.6.3 Revenue
12.7 Ypsomed AG
12.7.1 Overview
12.7.2 Initiatives & Recent Developments
12.7.3 Revenue
13. Insulin Pump - Company Analysis
13.1 Medtronic
13.1.1 Overview
13.1.2 Insulin Pump - Product Details
13.1.3 Insulin Pump - Latest Development & Trends
13.1.4 Revenue
13.2 Insulet Corporation
13.2.1 Overview
13.2.2 Insulin Pump - Product Details
13.2.3 Revenue
14. SMBG - Company Analysis
14.1 LifeScan Inc.
14.1.1 Overview
14.1.2 Revenue & Forecast
14.2 Abbott Laboratories
14.2.1 Overview
14.2.2 Abbott Laboratories SMBG Revenue & Forecast
15. CGM - Company Analysis
15.1 Dexcom Inc
15.1.1 Overview
15.1.2 Recent Development
15.1.3 Revenue& Forecast
15.2 Abbott Laboratories
15.2.1 Overview
15.2.2 Recent Development
15.3 Roche
15.3.1 Overview
15.3.2 Recent Development
List of Figures:
Figure 4-1: Global Ageing Population (Billion) 2015 - 2050
Figure 5-1: Australia - Diabetic Market (Billion US$), 2015 - 2019
Figure 5-2: Australia - Forecast for Market (Billion US$), 2020 - 2025
Figure 6-1: Australia - Diabetes Population (Thousand), 2011 - 2019
Figure 6-2: Australia- Forecast for Diabetes Population (Thousand), 2020 - 2025
Figure 6-3: Australia - Type 1 & Type 2 Diabetes Population (Thousand), 2011 - 2019
Figure 6-4: Australia - Forecast for Type 1 & Type 2 Diabetes Population (Thousand), 2020 - 2025
Figure 9-1: Australia - Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2013 - 2019
Figure 9-2: Australia - Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2020 - 2025
Figure 9-3: Australia - Self-Monitoring of Blood Glucose (SMBG) Market by Type 1 & Type 2 (Million US$), 2013 - 2019
Figure 9-4: Australia - Forecast for Self-Monitoring of Blood Glucose (SMBG) Market by Type 1 & Type 2 (Million US$), 2020 - 2025
Figure 9-5: Australia - Blood Glucose Test Strips Market (Million US$), 2013- 2019
Figure 9-6: Australia - Forecast for Blood Glucose Test Strips Market (Million US$), 2020 - 2025
Figure 9-7: Australia - Blood Glucose Test Strips Market by Type 1 & Type 2 (Million US$), 2013 - 2019
Figure 9-8: Australia - Forecast for Blood Glucose Test Strips Market by Type 1 & Type 2 (Million US$), 2020 - 2025
Figure 9-9: Australia - Blood Glucose Lancet Market (Million US$), 2013 - 2019
Figure 9-10: Australia - Forecast for Blood Glucose Lancet Market (Million US$), 2020 - 2025
Figure 9-11: Australia - Blood Glucose Lancet Market by Type 1 & Type 2 (Million US$), 2013 - 2019
Figure 9-12: Australia - Forecast for Blood Glucose Lancet Market by Type 1 & Type 2 (Million US$), 2020 - 2025
Figure 9-13: Australia - Blood Glucose Meter Market (Million US$), 2013 - 2019
Figure 9-14: Australia - Forecast for Blood Glucose Meter Market (Million US$), 2020 - 2025
Figure 9-15: Australia - Blood Glucose Meter Market by Type 1 & Type 2 (Million US$), 2013 - 2019
Figure 9-16: Australia - Forecast for Blood Glucose Meter Market by Type 1 & Type 2 (Million US$), 2020 - 2025
Figure 9-17: Australia - Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2013 - 2019
Figure 9-18: Australia - Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2020 - 2025
Figure 9-19: Australia - Self-Monitoring of Blood Glucose (SMBG) Users by Type 1 & Type 2 (Thousand), 2013 - 2019
Figure 9-20: Australia - Forecast for Self-Monitoring of Blood Glucose (SMBG) Users by Type 1 & Type 2 (Thousand), 2020 - 2025
Figure 14-7: Australia - Insulin Pen Users (Thousand), 2011 - 2019
Figure 14-8: Australia - Forecast for Insulin Pen Users (Thousand), 2020 - 2025
Figure 14-11: Australia - Disposable Insulin Pen Users (Thousands), 2011 - 2019
Figure 14-12: Australia - Forecast for Disposable Insulin Pen Users (Thousands), 2020 - 2025
Figure 14-15: Australia - Reusable Insulin Pen Users (Numbers), 2011 - 2019
Figure 14-16: Australia - Forecast for Reusable Insulin Pen Users (Numbers), 2020 - 2025
Figure 14-19: Australia - Smart Insulin Pen Users (Numbers), 2011 - 2019
Figure 14-20: Australia - Forecast for Smart Insulin Pen Users (Numbers), 2020 - 2025
Figure 14-5: Australia - Insulin Pen Market (Million US$), 2011 - 2019
Figure 14-6: Australia - Forecast for Insulin Pen Market (Million US$), 2020 - 2025
Figure 14-9: Australia - Disposable Insulin Pen Market (Million US$), 2011 - 2019
Figure 14-10: Australia - Forecast for Disposable Insulin Pen Market (Million US$), 2020 - 2025
Figure 14-13: Australia - Reusable Insulin Pen Market (Million US$), 2011 - 2019
Figure 14-14: Australia - Forecast for Reusable Insulin Pen Market (Million US$), 2020 - 2025
Figure 14-17: Australia - Smart Insulin Pen Market (Million US$), 2011 - 2019
Figure 14-18: Australia - Forecast for Smart Insulin Pen Market (Million US$), 2020 - 2025
Figure 14-21: Australia - Insulin Pen Needle Market (Million US$), 2011 - 2019
Figure 14-22: Australia - Forecast for Insulin Pen Needle Market (Million US$), 2020 - 2025
Figure 18-1: Australia - Insulin Pump Users (Number), 2011 - 2019
Figure 18-2: Australia - Forecast for Insulin Pump Users (Number), 2020 - 2025
Figure 18-3: Australia - Insulin Pump Users Type 1 & Type 2 (Number), 2011 - 2019
Figure 18-4: Australia - Forecast for Insulin Pump Users Type 1 & Type 2 (Number), 2020 - 2025
Figure 18-5: Australia - Insulin Pump Market (Million US$), 2015 - 2019
Figure 18-6: Australia - Forecast for Insulin Pump Market (Million US$), 2020 - 2025
Figure 18-7: Australia - Insulin Pump Market Type 1 & Type 2 (Million US$), 2015 - 2019
Figure 18-8: Australia - Forecast for Insulin Pump Market Type 1 & Type 2 (Million US$), 2020 - 2025
Figure 12-1: Global - B. Braun Melsungen AG Revenue (Million US$), 2014 - 2019
Figure 12-2: Global - Forecast for B. Braun Melsungen AG Revenue (Million US$), 2020 - 2025
Figure 12-3: Global - Eli Lilly and Company Revenue (Million US$), 2014 - 2019
Figure 12-4: Global - Forecast for Eli Lilly and Company Revenue (Million US$), 2020 - 2025
Figure 12-5: Global - Artsana S.p.A. Revenue (Million US$), 2016 - 2019
Figure 12-6: Global - Forecast for Artsana S.p.A. Revenue (Million US$), 2020 - 2025
Figure 12-7: Global - Becton, Dickinson and Company Revenue (Million US$), 2014 - 2019
Figure 12-8: Global - Forecast for Becton, Dickinson and Company Revenue (Million US$), 2020 - 2025
Figure 12-9: Global - Novo Nordisk A/S Revenue (Million US$), 2015 - 2019
Figure 12-10: Global - Forecast for Novo Nordisk A/S Revenue (Million US$), 2020 - 2026
Figure 12-11: Global - Owen Mumford Ltd. Revenue (Million US$), 2011 - 2019
Figure 12-12: Global - Forecast for Owen Mumford Ltd. Revenue (Million US$), 2020 - 2026
Figure 12-13: Global - Ypsomed AG Revenue (Million US$), 2013 - 2019
Figure 12-14: Global - Forecast for Ypsomed AG Revenue (Million US$), 2020 - 2026
Figure 13-1: Global - Medtronic Insulin Pump Revenue (Million US$), 2014 - 2019
Figure 13-2: Global - Forecast for Medtronic Insulin Pump Revenue (Million US$), 2019 - 2025
Figure 13-3: Global - Insulet Corporation Insulin Pump Revenue (Million US$), 2014 - 2019
Figure 13-4: Global - Forecast for Insulet Corporation Insulin Pump Revenue (Million US$), 2020 - 2025
Figure 14-1: Global - LifeScan SMBG Revenue (Million US$), 2014 - 2019
Figure 14-2: Global - Forecast for LifeScan SMBG Revenue (Million US$), 2020 - 2025
Figure 14-3: Global - Abbott Laboratories Diabetes Care Revenue (Million US$), 2014 - 2019
Figure 14-4: Global - Forecast for Abbott Laboratories Diabetes Care Revenue (Million US$), 2020 - 2025
Figure 15-1: Global - Dexcom Revenue (Million US$), 2014 - 2019
Figure 15-2: Global - Forecast for Dexcom Revenue (Million US$), 2020 - 2025
List of Tables:
Table 7-1: Australia - Diabetic Market Share by Types (Percent), 2013 - 2019
Table 7-2: Australia - Forecast for Diabetic Market Share by Types (Percent), 2020 - 2025
Table 11-1: Australia - Animas Vibe Differentiation Features
Table 11-2: Australia - Medtronic 530G with Enlite Differentiation Features
Table 11-3: Australia - Insulet OmniPod Differentiation Features
Table 11-4: Australia - Tandem t: slim Differentiation Features
Table 11-5: Australia - Roche Accu-Chek Combo Differentiation Features
Table 13-1: Medtronic - Latest Insulin Pump Products
Table 13-2: Acquisitions by Medtronic
Table 13-3: Insulet Corporation - Latest Products
Table 14-1: Acquisitions by Abbott
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Driver
4.2 Challenges
5. Australia Diabetes Market
6. Australia Diabetes Population
6.1 Type 1 & Type 2 Diabetes Population and Forecast
7. Market Share Analysis - Australia Diabetic
7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) - Australia Market & Users
8.1 Australia - CGM Market by Components
8.1.1 Glucose Sensor Market & Forecast
8.1.2 CGM Transmitter Market & Forecast
8.2 Australia - CGM User (2011 - 2025)
8.3 CGM Reimbursement in Australia
9. Blood Glucose Device (SMBG) - Australia Market & Users
9.1 Market
9.1.1 Type 1 & Type 2 (Diabetes)
9.2 Test Strips Market and Forecast
9.2.1 Type 1 & Type 2 (Diabetes)
9.3 Lancet Market and Forecast
9.3.1 Type 1 & Type 2 (Diabetes)
9.4 Meter Market and Forecast
9.4.1 Type 1 & Type 2 (Diabetes)
9.5 Blood Glucose Device (SMBG) Users
9.5.1 Type 1 & Type 2 (Diabetes)
9.6 Reimbursement of Blood Glucose Devices in Australia
10. Insulin Pen Market & User Analysis
10.1 Insulin Pen User
10.1.1 Disposable Insulin Pen Users
10.1.2 Reusable Insulin Pen Users
10.1.3 Smart Insulin Pen Users
10.2 Insulin Pen Market
10.2.1 Disposable Insulin Pen Market
10.2.2 Reusable Insulin Pen Market
10.2.3 Smart Insulin Pen Market
10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies
11. Insulin Pump Market & Users & Forecast
11.1 Insulin Pump Users & Forecast
11.1.1 Type 1 & Type 2 (Insulin Pump User & Forecast)
11.2 Insulin Pump Market & Forecast
11.2.1 Type 1 & Type 2 (Insulin Pump Market & Forecast)
11.3 Differentiation Points of Insulin Pump Products in Australia
11.3.1 Animas Vibe
11.3.2 Medtronic 530G with Enlite
11.3.3 Insulet OmniPod
11.3.4 Tandem t: slim
11.3.5 Roche Accu-Chek Combo
11.4 Training Model for Patients & HCP - of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
11.4.1 Medtronic
11.5 Insulet Corporation
11.5.1 Training Structure for New Patients - Insulet Corporation
11.6 Animas Corporation
11.6.1 Training Modules for New Patients
11.6.2 Training Modules for HCP (Health Care Professional)
11.7 Tandem Diabetes Care
11.8 Reimbursement Policies on Insulin Pump
12. Insulin Pen - Company Analysis
12.1 B. Braun Melsungen AG
12.1.1 Overview
12.1.2 Initiatives & Recent Developments
12.1.3 Revenue
12.2 Eli Lilly
12.2.1 Overview
12.2.2 Initiatives & Recent Developments
12.2.3 Revenue
12.3 Artsana S.p.A.,
12.3.1 Overview
12.3.2 Initiatives & Recent Developments
12.3.3 Revenue
12.4 BD
12.4.1 Overview
12.4.2 Initiatives & Recent Developments
12.4.3 Revenue
12.5 Novo Nordisk A/S
12.5.1 Overview
12.5.2 Initiatives & Recent Developments
12.5.3 Revenue
12.6 Owen Mumford Ltd.
12.6.1 Overview
12.6.2 Initiatives & Recent Developments
12.6.3 Revenue
12.7 Ypsomed AG
12.7.1 Overview
12.7.2 Initiatives & Recent Developments
12.7.3 Revenue
13. Insulin Pump - Company Analysis
13.1 Medtronic
13.1.1 Overview
13.1.2 Insulin Pump - Product Details
13.1.3 Insulin Pump - Latest Development & Trends
13.1.4 Revenue
13.2 Insulet Corporation
13.2.1 Overview
13.2.2 Insulin Pump - Product Details
13.2.3 Revenue
14. SMBG - Company Analysis
14.1 LifeScan Inc.
14.1.1 Overview
14.1.2 Revenue & Forecast
14.2 Abbott Laboratories
14.2.1 Overview
14.2.2 Abbott Laboratories SMBG Revenue & Forecast
15. CGM - Company Analysis
15.1 Dexcom Inc
15.1.1 Overview
15.1.2 Recent Development
15.1.3 Revenue& Forecast
15.2 Abbott Laboratories
15.2.1 Overview
15.2.2 Recent Development
15.3 Roche
15.3.1 Overview
15.3.2 Recent Development
List of Figures:
Figure 4-1: Global Ageing Population (Billion) 2015 - 2050
Figure 5-1: Australia - Diabetic Market (Billion US$), 2015 - 2019
Figure 5-2: Australia - Forecast for Market (Billion US$), 2020 - 2025
Figure 6-1: Australia - Diabetes Population (Thousand), 2011 - 2019
Figure 6-2: Australia- Forecast for Diabetes Population (Thousand), 2020 - 2025
Figure 6-3: Australia - Type 1 & Type 2 Diabetes Population (Thousand), 2011 - 2019
Figure 6-4: Australia - Forecast for Type 1 & Type 2 Diabetes Population (Thousand), 2020 - 2025
Figure 9-1: Australia - Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2013 - 2019
Figure 9-2: Australia - Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2020 - 2025
Figure 9-3: Australia - Self-Monitoring of Blood Glucose (SMBG) Market by Type 1 & Type 2 (Million US$), 2013 - 2019
Figure 9-4: Australia - Forecast for Self-Monitoring of Blood Glucose (SMBG) Market by Type 1 & Type 2 (Million US$), 2020 - 2025
Figure 9-5: Australia - Blood Glucose Test Strips Market (Million US$), 2013- 2019
Figure 9-6: Australia - Forecast for Blood Glucose Test Strips Market (Million US$), 2020 - 2025
Figure 9-7: Australia - Blood Glucose Test Strips Market by Type 1 & Type 2 (Million US$), 2013 - 2019
Figure 9-8: Australia - Forecast for Blood Glucose Test Strips Market by Type 1 & Type 2 (Million US$), 2020 - 2025
Figure 9-9: Australia - Blood Glucose Lancet Market (Million US$), 2013 - 2019
Figure 9-10: Australia - Forecast for Blood Glucose Lancet Market (Million US$), 2020 - 2025
Figure 9-11: Australia - Blood Glucose Lancet Market by Type 1 & Type 2 (Million US$), 2013 - 2019
Figure 9-12: Australia - Forecast for Blood Glucose Lancet Market by Type 1 & Type 2 (Million US$), 2020 - 2025
Figure 9-13: Australia - Blood Glucose Meter Market (Million US$), 2013 - 2019
Figure 9-14: Australia - Forecast for Blood Glucose Meter Market (Million US$), 2020 - 2025
Figure 9-15: Australia - Blood Glucose Meter Market by Type 1 & Type 2 (Million US$), 2013 - 2019
Figure 9-16: Australia - Forecast for Blood Glucose Meter Market by Type 1 & Type 2 (Million US$), 2020 - 2025
Figure 9-17: Australia - Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2013 - 2019
Figure 9-18: Australia - Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2020 - 2025
Figure 9-19: Australia - Self-Monitoring of Blood Glucose (SMBG) Users by Type 1 & Type 2 (Thousand), 2013 - 2019
Figure 9-20: Australia - Forecast for Self-Monitoring of Blood Glucose (SMBG) Users by Type 1 & Type 2 (Thousand), 2020 - 2025
Figure 14-7: Australia - Insulin Pen Users (Thousand), 2011 - 2019
Figure 14-8: Australia - Forecast for Insulin Pen Users (Thousand), 2020 - 2025
Figure 14-11: Australia - Disposable Insulin Pen Users (Thousands), 2011 - 2019
Figure 14-12: Australia - Forecast for Disposable Insulin Pen Users (Thousands), 2020 - 2025
Figure 14-15: Australia - Reusable Insulin Pen Users (Numbers), 2011 - 2019
Figure 14-16: Australia - Forecast for Reusable Insulin Pen Users (Numbers), 2020 - 2025
Figure 14-19: Australia - Smart Insulin Pen Users (Numbers), 2011 - 2019
Figure 14-20: Australia - Forecast for Smart Insulin Pen Users (Numbers), 2020 - 2025
Figure 14-5: Australia - Insulin Pen Market (Million US$), 2011 - 2019
Figure 14-6: Australia - Forecast for Insulin Pen Market (Million US$), 2020 - 2025
Figure 14-9: Australia - Disposable Insulin Pen Market (Million US$), 2011 - 2019
Figure 14-10: Australia - Forecast for Disposable Insulin Pen Market (Million US$), 2020 - 2025
Figure 14-13: Australia - Reusable Insulin Pen Market (Million US$), 2011 - 2019
Figure 14-14: Australia - Forecast for Reusable Insulin Pen Market (Million US$), 2020 - 2025
Figure 14-17: Australia - Smart Insulin Pen Market (Million US$), 2011 - 2019
Figure 14-18: Australia - Forecast for Smart Insulin Pen Market (Million US$), 2020 - 2025
Figure 14-21: Australia - Insulin Pen Needle Market (Million US$), 2011 - 2019
Figure 14-22: Australia - Forecast for Insulin Pen Needle Market (Million US$), 2020 - 2025
Figure 18-1: Australia - Insulin Pump Users (Number), 2011 - 2019
Figure 18-2: Australia - Forecast for Insulin Pump Users (Number), 2020 - 2025
Figure 18-3: Australia - Insulin Pump Users Type 1 & Type 2 (Number), 2011 - 2019
Figure 18-4: Australia - Forecast for Insulin Pump Users Type 1 & Type 2 (Number), 2020 - 2025
Figure 18-5: Australia - Insulin Pump Market (Million US$), 2015 - 2019
Figure 18-6: Australia - Forecast for Insulin Pump Market (Million US$), 2020 - 2025
Figure 18-7: Australia - Insulin Pump Market Type 1 & Type 2 (Million US$), 2015 - 2019
Figure 18-8: Australia - Forecast for Insulin Pump Market Type 1 & Type 2 (Million US$), 2020 - 2025
Figure 12-1: Global - B. Braun Melsungen AG Revenue (Million US$), 2014 - 2019
Figure 12-2: Global - Forecast for B. Braun Melsungen AG Revenue (Million US$), 2020 - 2025
Figure 12-3: Global - Eli Lilly and Company Revenue (Million US$), 2014 - 2019
Figure 12-4: Global - Forecast for Eli Lilly and Company Revenue (Million US$), 2020 - 2025
Figure 12-5: Global - Artsana S.p.A. Revenue (Million US$), 2016 - 2019
Figure 12-6: Global - Forecast for Artsana S.p.A. Revenue (Million US$), 2020 - 2025
Figure 12-7: Global - Becton, Dickinson and Company Revenue (Million US$), 2014 - 2019
Figure 12-8: Global - Forecast for Becton, Dickinson and Company Revenue (Million US$), 2020 - 2025
Figure 12-9: Global - Novo Nordisk A/S Revenue (Million US$), 2015 - 2019
Figure 12-10: Global - Forecast for Novo Nordisk A/S Revenue (Million US$), 2020 - 2026
Figure 12-11: Global - Owen Mumford Ltd. Revenue (Million US$), 2011 - 2019
Figure 12-12: Global - Forecast for Owen Mumford Ltd. Revenue (Million US$), 2020 - 2026
Figure 12-13: Global - Ypsomed AG Revenue (Million US$), 2013 - 2019
Figure 12-14: Global - Forecast for Ypsomed AG Revenue (Million US$), 2020 - 2026
Figure 13-1: Global - Medtronic Insulin Pump Revenue (Million US$), 2014 - 2019
Figure 13-2: Global - Forecast for Medtronic Insulin Pump Revenue (Million US$), 2019 - 2025
Figure 13-3: Global - Insulet Corporation Insulin Pump Revenue (Million US$), 2014 - 2019
Figure 13-4: Global - Forecast for Insulet Corporation Insulin Pump Revenue (Million US$), 2020 - 2025
Figure 14-1: Global - LifeScan SMBG Revenue (Million US$), 2014 - 2019
Figure 14-2: Global - Forecast for LifeScan SMBG Revenue (Million US$), 2020 - 2025
Figure 14-3: Global - Abbott Laboratories Diabetes Care Revenue (Million US$), 2014 - 2019
Figure 14-4: Global - Forecast for Abbott Laboratories Diabetes Care Revenue (Million US$), 2020 - 2025
Figure 15-1: Global - Dexcom Revenue (Million US$), 2014 - 2019
Figure 15-2: Global - Forecast for Dexcom Revenue (Million US$), 2020 - 2025
List of Tables:
Table 7-1: Australia - Diabetic Market Share by Types (Percent), 2013 - 2019
Table 7-2: Australia - Forecast for Diabetic Market Share by Types (Percent), 2020 - 2025
Table 11-1: Australia - Animas Vibe Differentiation Features
Table 11-2: Australia - Medtronic 530G with Enlite Differentiation Features
Table 11-3: Australia - Insulet OmniPod Differentiation Features
Table 11-4: Australia - Tandem t: slim Differentiation Features
Table 11-5: Australia - Roche Accu-Chek Combo Differentiation Features
Table 13-1: Medtronic - Latest Insulin Pump Products
Table 13-2: Acquisitions by Medtronic
Table 13-3: Insulet Corporation - Latest Products
Table 14-1: Acquisitions by Abbott
Note: Product cover images may vary from those shown
- B. Braun Melsungen AG
- Eli Lilly and Company
- Artsana S.p.A
- BD
- Novo Nordisk A/S
- Owen Mumford Ltd
- Ypsomed AG
- Medtronic
- Insulet Corporation
- LifeScan Inc.
- Abbott Laboratories
- Roche
- Dexcom Inc
Note: Product cover images may vary from those shown
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
